Neuropathic pain: clinical classification and assessment in patients with pain due to cancer

The comparison of 3 approaches with neuropathic cancer pain diagnosis demands that careful etiological assessment and standardized clinical criteria be applied to this clinical condition.

[1]  A. Caraceni,et al.  Cancer Pain Assessment and Classification , 2019, Cancers.

[2]  R. Treede,et al.  The IASP classification of chronic pain for ICD-11: chronic cancer-related pain , 2019, Pain.

[3]  V. Siafaka,et al.  Detection of Neuropathic Pain in End‐Stage Cancer Patients: Diagnostic Accuracy of Two Questionnaires , 2018, Pain practice : the official journal of World Institute of Pain.

[4]  M. Hjermstad,et al.  Neuropathic pain in cancer: systematic review, performance of screening tools and analysis of symptom profiles , 2017, British journal of anaesthesia.

[5]  P. Lawlor,et al.  Cancer Pain With a Neuropathic Component: A Cross-sectional Study of Its Clinical Characteristics, Associated Psychological Distress, Treatments, and Predictors at Referral to a Cancer Pain Clinic. , 2017, Journal of pain and symptom management.

[6]  D. Bouhassira,et al.  Prevalence and incidence of chronic pain with or without neuropathic characteristics in patients with cancer , 2017, Pain.

[7]  L. Stitt,et al.  Sensitivity of the DN4 in Screening for Neuropathic Pain Syndromes , 2017, The Clinical journal of pain.

[8]  F. Murtagh,et al.  A systematic review of the effectiveness of palliative interventions to treat rectal tenesmus in cancer , 2017, Palliative medicine.

[9]  Laura M J Hochstenbach,et al.  Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis. , 2016, Journal of pain and symptom management.

[10]  F. Ruggeri,et al.  Prevalence of Neuropathic Pain in Cancer Patients: Pooled Estimates From a Systematic Review of Published Literature and Results From a Survey Conducted in 50 Italian Palliative Care Centers. , 2016, Journal of pain and symptom management.

[11]  Blair H. Smith,et al.  Neuropathic pain: an updated grading system for research and clinical practice , 2016, Pain.

[12]  J. Villoria,et al.  Prevalence of pain and relative diagnostic performance of screening tools for neuropathic pain in cancer patients: A cross‐sectional study , 2015, European journal of pain.

[13]  M. Bennett,et al.  Classification of neuropathic pain in cancer patients , 2015, Current opinion in supportive and palliative care.

[14]  S. Kaasa,et al.  Classification of neuropathic pain in cancer patients: A Delphi expert survey report and EAPC/IASP proposal of an algorithm for diagnostic criteria , 2014, PAIN®.

[15]  A. Dickenson,et al.  Pain and nociception: mechanisms of cancer-induced bone pain. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Roman Rolke,et al.  Confirming neuropathic pain in cancer patients: Applying the NeuPSIG grading system in clinical practice and clinical research , 2014, PAIN®.

[17]  M. Hjermstad,et al.  Neuropathic cancer pain: Prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative–Computerised Symptom Assessment study , 2013, Palliative medicine.

[18]  D. Currow,et al.  Can the LANSS scale be used to classify pain in chronic cancer pain trials? , 2013, Supportive Care in Cancer.

[19]  G. Marfia,et al.  Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy , 2012, Diabetic medicine : a journal of the British Diabetic Association.

[20]  M. Hjermstad,et al.  Prevalence and aetiology of neuropathic pain in cancer patients: A systematic review , 2012, PAIN.

[21]  J. Farrar,et al.  Expert conference on cancer pain assessment and classification—the need for international consensus: working proposals on international standards , 2011, BMJ Supportive & Palliative Care.

[22]  E. Kalso,et al.  A new definition of neuropathic pain , 2011, PAIN®.

[23]  E. Miranda,et al.  First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the On study. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  Blair H. Smith,et al.  NeuPSIG guidelines on neuropathic pain assessment , 2011, PAIN®.

[25]  K. Foley,et al.  Types and epidemiology of cancer-related neuropathic pain: the intersection of cancer pain and neuropathic pain. , 2010, The oncologist.

[26]  S. Deandrea,et al.  Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group , 2009, British Journal of Cancer.

[27]  C. Urch,et al.  Pathophysiology of somatic, visceral, and neuropathic cancer pain , 2008 .

[28]  R. Baron,et al.  painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain , 2006, Current medical research and opinion.

[29]  A. Vigano,et al.  A multicenter study of the revised Edmonton Staging System for classifying cancer pain in advanced cancer patients. , 2005, Journal of pain and symptom management.

[30]  Bernard Laurent,et al.  Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4) , 2005, Pain.

[31]  M. Bennett.  Gabapentin significantly improves analgesia in people receiving opioids for neuropathic cancer pain. , 2005, Cancer treatment reviews.

[32]  M. Maltoni,et al.  Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  E. Zecca,et al.  Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey , 2004, Palliative Medicine.

[34]  M. Bennett,et al.  The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs , 2001, Pain.

[35]  A. Caraceni,et al.  An international survey of cancer pain characteristics and syndromes , 1999, PAIN.

[36]  Katherine R. Edwards,et al.  A validation study of an Italian version of the brief pain inventory (Breve questionario per la valutazione del dolore) , 1996, Pain.

[37]  L. Radbruch,et al.  Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service , 1996, Pain.

[38]  E. Bruera,et al.  A prospective multicenter assessment of the Edmonton staging system for cancer pain. , 1995, Journal of pain and symptom management.

[39]  H. Thaler,et al.  Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms , 1994, Neurology.

[40]  Carol L. Davis,et al.  Oxford Textbook of Palliative Medicine , 1994, British Journal of Cancer.

[41]  G. Gonzales,et al.  The impact of a comprehensive evaluation in the management of cancer pain , 1991, Pain.

[42]  K. Foley.  Pain syndromes in patients with cancer. , 1987, The Medical clinics of North America.

[43]  K. Foley,et al.  The natural history of lumbosacral plexopathy in cancer , 1985, Neurology.

[44]  K. Foley,et al.  Brachial plexus lesions in patients with cancer=100 cases , 1981, Neurology.

[45]  Jacob Cohen.  A Coefficient of Agreement for Nominal Scales , 1960 .

[46]  M. Hjermstad,et al.  Comparisons of patient and physician assessment of pain-related domains in cancer pain classification: results from a large international multicenter study. , 2014, The journal of pain : official journal of the American Pain Society.